Duration: 4 minutes
Acute kidney injury (AKI) is one of the most significant and potentially deadly diseases affecting patients in the ICU. Now hear from industry experts about how the first commercially available test is allowing for early AKI risk assessment in these ICU patients. The NephroCheck® Test allows clinicians to identify patients at risk to develop moderate to severe AKI and to implement strategies which can help prevent kidney damage or death.
Disclosures: This promotional educational activity is brought to you by Ortho Clinical Diagnostics and is not certified for Continuing Medical Education (CME). The speakers are presenting on behalf of Ortho Clinical Diagnostics and must present information in accordance with applicable and/or local regulatory country requirements.
About Our Speakers:
About Our Speakers:
Jeffery Vender, MD
Anesthesiologist & Critical Care Physician
North Shore Hospital Health System, Evanston, IL
About Our Speakers:
Harold M. Szerlip, MD
Nephrologist & Director, Renal Division
Baylor University Medical Center, Dallas, TX
About Our Speakers:
Peter McCullough, MD
Cardiologist, Vice Chief of Medicine
Baylor University Medical Center, Dallas, TX